Here, we present a protocol of adult mouse terminal phalanx amputation to investigate mammalian blastema formation and intramembranous ossification, analyzed by fluorescent immunohistochemistry and sequential in-vivo microcomputed tomography.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
Here, we present a protocol of adult mouse terminal phalanx amputation to investigate mammalian blastema formation and intramembranous ossification, analyzed by fluorescent immunohistochemistry and sequential in-vivo microcomputed tomography.
Here, we present a protocol of adult mouse distal terminal phalanx (P3) amputation, a procedurally simple and reproducible mammalian model of epimorphic regeneration, which involves blastema formation and intramembranous ossification analyzed by fluorescence immunohistochemistry and sequential in-vivo microcomputed tomography (μCT). Mammalian regeneration is restricted to amputations transecting the distal region of the terminal phalanx (P3); digits amputated at more proximal levels fail to regenerate and undergo fibrotic healing and scar formation. The regeneration response is mediated by the formation of a proliferative blastema, followed by bone regeneration via intramembranous ossification to restore the amputated skeletal length. P3 amputation is a preclinical model to investigate epimorphic regeneration in mammals, and is a powerful tool for the design of therapeutic strategies to replace fibrotic healing with a successful regenerative response. Our protocol uses fluorescence immunohistochemistry to 1) identify early-and-late blastema cell populations, 2) study revascularization in the context of regeneration, and 3) investigate intramembranous ossification without the need for complex bone stabilization devices. We also demonstrate the use of sequential in vivo μCT to create high resolution images to examine morphological changes after amputation, as well as quantify volume and length changes in the same digit over the course of regeneration. We believe this protocol offers tremendous utility to investigate both epimorphic and tissue regenerative responses in mammals.
Mammals, including humans and mice, have the capacity to regenerate the tips of their digits after distal amputation of the terminal phalanx (P3)1,2,3. In mice, the regeneration response is amputation-level-dependent; increasingly proximal digit amputations display a progressively attenuated regenerative response until complete regenerative failure at amputations transecting and proximal to the P3 nail matrix4,5,6,7,8
Access restricted. Please log in or start a trial to view this content.
All animal use and techniques were in compliance with the standard operating procedures of the Institutional Animal Care and Use Committee of Texas A&M University.
1. Adult Mouse Hind Limb Distal P3 Amputation
Access restricted. Please log in or start a trial to view this content.
Adult mouse regenerating P3 digits at 6/7 DPA (Figure 2A-D), 9 DPA (Figure 2E-H), and 10 DPA (Figure 2I-L) were immunostained with antibodies to Runx2, OSX, and PCNA to visualize intramembranous bone regeneration, and immunostained with antibodies to CXCR4 and vWF to visualize blastema formation. Representative μCT renderings of digits scanned prior to amputation and at various time.......
Access restricted. Please log in or start a trial to view this content.
This protocol describes a standardized procedure of adult mouse distal P3 amputation, fluorescent immunohistochemical staining to visualize and investigate blastema formation and intramembranous ossification, and sequential in-vivo µCT scanning to identify bone morphological, volume, and length changes post amputation. P3 amputation is a unique, procedurally simple, and reproducible model to analyze a pro-regenerative wound environment that triggers blastema formation. Furthermore, the P3 digit model offers numerous.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
We thank members of the Muneoka Lab and the Texas Institute for Genomic Medicine (TIGM). This work was supported by Texas A&M University.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Protein Block Serum Free | DAKO | X0909 | Ready to use |
| Mouse anti-PCNA antibody | Abcam | ab29 | 1:2000 dilution |
| Rat anti-CXCR4 antibody | R&D Systems | MAB21651 | 1:500 dilution |
| Rabbit anti-human vWF XIII antibody | DAKO | A0082 | 1:800 dilution |
| Rabbit anti-osterix, SP7 antibody | Abcam | ab22552 | 1:400 dilution |
| Rabbit anti-Runx2 antibody | Sigma-Aldrich Co. | HPA022040 | 1:250 dilution |
| Alexa Fluor 647-conjugated goat anti-mouse IgG (H+L) | Invitrogen | A21235 | 1:500 dilution |
| Alexa Fluor 488-conjugated goat anti-rabbit IgG (H+L) | Invitrogen | A11008 | 1:500 dilution |
| Alexa Fluor 568-conjugated goat anti-rat IgG (H+L) | Invitrogen | A11077 | 1:500 dilution |
| Prolong Gold antifade reagent | Invitrogen | P36930 | Ready to use |
| Surgipath Decalicifier 1 | Leica Biosystems | 3800400 | Ready to use |
| Z-Fix, Aqueous buffered zinc formalin fixative | Anatech LTD | 174 | Ready to use |
| CD-1 Female Mouse | Envigo | ICR(CD-1) | 8-12-weeks-old |
| vivaCT 40 | SCANCO Medical |
Access restricted. Please log in or start a trial to view this content.